Related Experiment Video

Updated: Jul 31, 2026

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications

Published on: November 17, 2015

Liposomes and nanoparticles in the treatment of intracellular bacterial infections

P Couvreur1, E Fattal, A Andremont

  • 1Laboratoire de Pharmacie Galénique et Biopharmacie, URA CNRS 1218, University of Paris XI, France.

Pharmaceutical Research
|September 1, 1991
PubMed

Insights

Treating intracellular bacterial infections is challenging due to poor antibiotic penetration. Liposomes and nanoparticles offer promising solutions for targeted antibiotic delivery into cells, improving treatment efficacy.

Area of Science:

  • Pharmacology
  • Microbiology
  • Nanotechnology

Background:

  • Intracellular bacterial infections pose treatment challenges due to limited antibiotic efficacy within host cells.
  • Conventional antibiotics struggle with poor diffusion, retention, and activity at the acidic lysosomal pH.
  • This necessitates novel strategies for effective intracellular antimicrobial delivery.

Purpose of the Study:

  • To review the potential of liposomes and nanoparticles for targeted antibiotic therapy of intracellular bacterial infections.
  • To evaluate the pharmaceutical advantages and limitations of these submicron delivery systems.
  • To highlight advancements in treating challenging intracellular microbial diseases.

Main Methods:

  • Literature review of studies on liposomes and nanoparticles for intracellular drug delivery.
  • Analysis of mechanisms for cellular entry and intracellular targeting.
  • Assessment of drug loading, release kinetics, and therapeutic outcomes.

Main Results:

  • Liposomes and nanoparticles can mimic bacterial entry, delivering antibiotics into phagosomes and lysosomes.
  • These carriers demonstrate enhanced intracellular antibiotic concentration and efficacy.
  • Various formulations show potential for improved treatment of intracellular infections.

Conclusions:

  • Submicron drug delivery systems like liposomes and nanoparticles are highly promising for intracellular bacterial infections.
  • They offer pharmaceutical advantages in overcoming limitations of conventional antibiotic therapy.
  • Further research and development are crucial for clinical translation and optimizing therapeutic outcomes.

More Related Videos

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins11:30

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes08:44

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

Published on: July 30, 2020

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
Intracellular Movement of Viruses and Bacteria01:10

Intracellular Movement of Viruses and Bacteria

Intracellular bacteria and viruses often comprise a group of highly infectious pathogens that can cause several diseases. Bacterial pathogens include those belonging to the genus Rickettsia responsible for conditions such as rocky mountain spotted fever and the Mediterranean spotted fever; Chlamydia, a genus responsible for a sexually transmitted disease; Coxiella burnetii, an agent responsible for Q fever. Viral pathogens include vaccinia—a poxvirus, and herpes simplex virus—a virus that...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...